Abstract
Recovery from traumatic brain injury (TBI) is variable despite similarities in the severity or mechanism of injury. The study of genetic polymorphisms offers an avenue for explaining individual differences in recovery and outcome following TBI. The current paper reviews the role that genetic polymorphisms may play in influencing recovery and quality of life following TBI. Investigating the role of polymorphisms on recovery from TBI may contribute to a better understanding of individual variations in outcome and has the potential to lead to earlier and more targeted interventions and rehabilitation based on a patient’s genetic makeup. By outlining what has been discovered about the relationship between polymorphisms and TBI we hope to both inform the medical community about the potential for polymorphisms to influence recovery following TBI and provide a roadmap to researchers about the gaps in research within this population.
Keywords: Traumatic Brain Injury, Polymorphisms, Genes.
Current Pharmaceutical Design
Title:Neurobiological Influences on Recovery from Traumatic Brain Injury: The Role of Genetic Polymorphisms
Volume: 20 Issue: 26
Author(s): Starla M. Weaver and Jaclyn N. Portelli
Affiliation:
Keywords: Traumatic Brain Injury, Polymorphisms, Genes.
Abstract: Recovery from traumatic brain injury (TBI) is variable despite similarities in the severity or mechanism of injury. The study of genetic polymorphisms offers an avenue for explaining individual differences in recovery and outcome following TBI. The current paper reviews the role that genetic polymorphisms may play in influencing recovery and quality of life following TBI. Investigating the role of polymorphisms on recovery from TBI may contribute to a better understanding of individual variations in outcome and has the potential to lead to earlier and more targeted interventions and rehabilitation based on a patient’s genetic makeup. By outlining what has been discovered about the relationship between polymorphisms and TBI we hope to both inform the medical community about the potential for polymorphisms to influence recovery following TBI and provide a roadmap to researchers about the gaps in research within this population.
Export Options
About this article
Cite this article as:
Weaver M. Starla and Portelli N. Jaclyn, Neurobiological Influences on Recovery from Traumatic Brain Injury: The Role of Genetic Polymorphisms, Current Pharmaceutical Design 2014; 20 (26) . https://dx.doi.org/10.2174/13816128113196660657
DOI https://dx.doi.org/10.2174/13816128113196660657 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Radiosensitizing Effect of Electrochemotherapy: A Systematic Review of Protocols and Efficiency
Current Drug Targets Signaling Through Rho GTPase Pathway as Viable Drug Target
Current Medicinal Chemistry Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions
Current Drug Targets Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage
Current Pharmaceutical Design Eph/ephrin Signaling as a Potential Therapeutic Target After Central Nervous System Injury
Current Pharmaceutical Design Davunetide: Peptide Therapeutic in Neurological Disorders
Current Medicinal Chemistry The Multiple Aspects of Stroke and Stem Cell Therapy
Current Molecular Medicine Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma
Current Gene Therapy Effect of Synthetic Cannabinoid HU210 on Memory Deficits and Neuropathology in Alzheimers Disease Mouse Model
Current Alzheimer Research Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products
Current Medicinal Chemistry Editorial (Thematic Issue: Critical Appraisal of Ischemic Stroke Pathophysiology: Road to Cerebral Resuscitation? Part I)
Current Medicinal Chemistry Progression of Renal Dysfunction in Patients with Cardiovascular Disease
Current Cardiology Reviews Programming Apoptosis and Autophagy with Novel Approaches for Diabetes Mellitus
Current Neurovascular Research Heart Failure in Acute Ischemic Stroke
Current Cardiology Reviews A Systems Biology Consideration of the Vasculopathy of Sickle Cell Anemia: The Need for Multi-Modality Chemo-Prophylaxis
Cardiovascular & Hematological Disorders-Drug Targets Effects of Subhypothermia on Ca2+, Mg2+, Excitatory Amino Acids and Plasma Endothelin in Brain Tissues of Mice with Acute Cerebral Infarction
Vascular Disease Prevention (Discontinued) PAX6 expression may be protective against dopaminergic cell loss in Parkinson’s disease
CNS & Neurological Disorders - Drug Targets Protective Effects and Mechanisms of Action of Ulinastatin against Cerebral Ischemia-Reperfusion Injury
Current Pharmaceutical Design Enkephalin-Fentanyl Multifunctional Opioids as Potential Neuroprotectants for Ischemic Stroke Treatment
Current Pharmaceutical Design Pharmacological Modulation of Nitric Oxide Release: New Pharmacological Perspectives, Potential Benefits and Risks
Current Medicinal Chemistry